89 related articles for article (PubMed ID: 20540035)
1. A protocolized approach to vancomycin dosing in conventional hemodialysis.
Panais R; Hirsch DJ; Dipchand C; Storsley L; Finkle SN
J Nephrol; 2010; 23(5):569-74. PubMed ID: 20540035
[TBL] [Abstract][Full Text] [Related]
2. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
4. Weight-based loading of vancomycin in patients on hemodialysis.
Brown M; Polisetty R; Gracely EJ; Cuhaci B; Schlecht HP
Clin Infect Dis; 2011 Jul; 53(2):164-6. PubMed ID: 21690623
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
Soto Guerrero Y; Hernández Castillo R; Santiago E; Ramírez Yuch N; Jaume Anselmi F; Jové R; Flores R; Lebrón R; Ramírez Rivera J
Bol Asoc Med P R; 2012; 104(3):10-4. PubMed ID: 23156886
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
Vandecasteele SJ; De Bacquer D; De Vriese AS
Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin dosing in patients on intermittent hemodialysis.
Vandecasteele SJ; De Vriese AS
Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
[TBL] [Abstract][Full Text] [Related]
8. Optimizing initial vancomycin dosing in burn patients.
Elligsen M; Walker SA; Walker SE; Simor A
Burns; 2011 May; 37(3):406-14. PubMed ID: 21095062
[TBL] [Abstract][Full Text] [Related]
9. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
10. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
[TBL] [Abstract][Full Text] [Related]
11. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
Zhang M; Dresser L; Battistella M
CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
[No Abstract] [Full Text] [Related]
12. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
Beigi AA; Khansoltani S; Masoudpour H; Atapour AA; Eshaghian A; Khademi EF
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):54-8. PubMed ID: 20061693
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.
D'Agata EM; Green WK; Schulman G; Li H; Tang YW; Schaffner W
Clin Infect Dis; 2001 Jan; 32(1):23-9. PubMed ID: 11112676
[TBL] [Abstract][Full Text] [Related]
14. [Vancomycin dosing in hemodialysis patients].
Castellano I; González Castillo PM; Covarsí A; Martínez Sánchez J; Suárez Santisteban MA; Gallego S; Marigliano N
Nefrologia; 2008; 28(6):607-12. PubMed ID: 19016633
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
Maxson R; Pate J; Starr J
Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.
Chaijamorn W; Wanakamanee U
Int J Antimicrob Agents; 2014 Oct; 44(4):367-8. PubMed ID: 25127656
[No Abstract] [Full Text] [Related]
18. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
19. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area.
Eguia JM; Liu C; Moore M; Wrone EM; Pont J; Gerberding JL; Chambers HF
Clin Infect Dis; 2005 Jun; 40(11):1617-24. PubMed ID: 15889359
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
